Prism Ideas, a leading independent provider of medical communications and drug development consultancy services, has announced that the company has appointed Nigel Brooksby, as non-executive chairman, fulfilling a key component in the company's continuing strategy for growth. Brooksby's global pharmaceutical experience will assist Prism Ideas to further develop its business across key regions and places the company in an optimal position for expansion into new markets.

Brooksby has more than 35 years' experience in the life sciences industry, culminating in his position as chairman and managing director for Sanofi-Aventis UK and also successfully leading the UK's Association of the British Pharmaceutical Industry (ABPI) for two years. Earlier this year Brooksby was made chairman of the board of trustees of the Primary Care Cardiovascular Society and has recently been invited to join the advisory board of the Imperial Clinical Trials Unit at Imperial College London. In May, the secretary of state for the Department for Business, Innovation and Skills (BIS) appointed him as a member of the Industrial Development Advisory Board.

Prism Ideas' unique combination of services and in-house medical expertise has made the company a leading international medical communications provider. The company, who recently won a Queen's Award for Enterprise, offers its customers a wide breadth of services covering clinical programme consultancy, clinical trial support and medical marketing. Prism Ideas' commitment to the development of innovative offerings is supported by its expert team whose knowledge and in-depth understanding of the industry are the foundation of its services to the company's clients.

 "Prism Ideas is at a very exciting time in its development with a strong reputation for delivering scientific excellence and innovation", says Nigel Brooksby. "I am delighted to be joining the company's leadership team and am looking forward to the opportunity to help build on its success."

Dr. James Sawyer, CEO of Prism Ideas, comments: "Nigel's incredible track-record in the pharmaceutical industry makes him a great addition to our management team.  His global knowledge of the industry will be an invaluable asset as we establish our new offices overseas and develop broader services for our clients. By becoming our chairman Nigel will offer Prism Ideas unrivaled advice and support to continue to ensure that we maintain the progress and direction that has made the company a success."

For further information about Prism Ideas, please call +44 (0) 1270 621 724 or visit www.prismideas.com 

About Prism Ideas

Prism Ideas is an independent company providing drug development consultancy and expert medical affairs support to the pharmaceutical industry. The company offers a full range of medical communications services including congress materials, journal articles, publication plans, advisory boards and advocacy development; drug development consultancy and expert medical support throughout the clinical evaluation drugs from medical monitoring of early stage clinical studies through to post-marketing activities.   

Prism's knowledge of industry, together with a thorough understanding of the science, ensures that clinical trials and medical communications maintain the highest scientific quality whilst meeting the needs of the pharmaceutical industry.  

Prism currently has offices in the UK and Switzerland with plans to establish a U.S base during 2010.